| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -24.41M | 8.26M | 2.27M | 65.91M | 44.36M | 15.81M |
| Gross Profit | -24.41M | 8.25M | -3.28M | 58.47M | 41.20M | 14.60M |
| EBITDA | 0.00 | 6.18M | 28.40M | 0.00 | 0.00 | 0.00 |
| Net Income | -32.06M | 6.18M | -5.66M | 63.41M | 42.53M | 14.59M |
Balance Sheet | ||||||
| Total Assets | 457.12M | 519.96M | 542.85M | 559.31M | 378.86M | 146.21M |
| Cash, Cash Equivalents and Short-Term Investments | 9.85M | 9.60M | 60.67M | 99.20M | 198.05M | 60.15M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.83M | 666.94K | 2.15M | 3.05M | 2.38M | 1.08M |
| Stockholders Equity | 455.29M | 519.29M | 540.70M | 556.26M | 376.48M | 145.13M |
Cash Flow | ||||||
| Free Cash Flow | 18.95M | 8.28M | 23.81M | 2.46M | 5.61M | -1.65M |
| Operating Cash Flow | 18.95M | 8.28M | 23.81M | 2.46M | 5.61M | -1.65M |
| Investing Cash Flow | -7.99M | -31.77M | -66.17M | -193.17M | -56.54M | -34.08M |
| Financing Cash Flow | -20.20M | -27.59M | -20.68M | 116.37M | 188.82M | 80.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £389.89M | 7.48 | 44.99% | 5.73% | ― | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | £270.73M | -1.21 | -6.58% | 8.18% | -9.72% | -25.25% | |
62 Neutral | £143.88M | 11.98 | 17.51% | 17.93% | -16.53% | -44.15% | |
45 Neutral | £10.49M | -4.39 | -22.43% | ― | ― | ― | |
44 Neutral | ― | -1.48 | -47.36% | 3.45% | ― | ― |